Thank you, Kim. BIO-key's Q1 2022 revenue increased to $1.94 million from $1.89 million in Q1 2021, driven by 205% increase in software license fees as well as an increase in services revenue, which more than offset the decline in the hardware revenue. Q1 2021 included $680,000 in hardware revenue related to the initial product shipments for the large scale ID project in Africa. Gross profit grew to $1.6 million in Q1, 2022 from $1.1 million in Q1, 2021 due mainly to the increase in higher margin license fee revenue as a percentage of total revenue in the current year period. Operating expenses increased to $2.6 million in Q1, 2022 from $2 million in Q1, 2021 due to a $400,000 increase in research, development and engineering expense for upgraded MobileAuth and IDaaS solution and the $300,000 increase in SG&A and other expenses associated with the Swivel Secure Europe purchase. The company reported a Q1, 2022 operating loss of $1 million versus $800,000 in Q1 2021 as greater profit - gross profit was more than offset by higher operating expenses incurred to support our growth. BIO-key reported a Q1, 2022 net loss available to common shareholders of $1 million or $0.12 per share as, compared to a net loss of $900,000 or $0.11 per share in Q1, 2021. Total other income was $131 in Q1, 2022 versus an expense of $15,400 in Q1, 2021. BIO-key ended the quarter with $13.6 million of current assets, including $5.8 million of cash and cash equivalents, $2 million of accounts receivable and $5 million in inventory. Net working capital was $10.1 million and the book value of stockholders' equity was $15.3 million or $1.82 per share. In Q1, 2022, we invested approximately $550,000 in net working capital to support our growth and $1.1 million of net acquired cash related to our Swivel Secure Europe. Thus far, we have managed our supply chain without any negative impact to our business, and we have invested as necessary in preparations for the increasing business volume. And now I believe we can turn the call back to the operator for investor questions.